Literature DB >> 34313899

Telephone Patient Navigation Increases Follow-Up Hepatitis B Care in the Postpartum Period for Immigrants Living in New York City.

Jessie Schwartz1, Angelica Bocour2, Liz Tang2, Farma Pene2, Nirah Johnson2, Julie Lazaroff3, Miranda S Moore2, Ann Winters2.   

Abstract

Hepatitis B is a major public health threat which leads to serious liver disease or cancer and disproportionately impacts immigrants. Pregnant people are routinely tested for hepatitis B to prevent perinatal transmission but may themselves not receive appropriate education and referrals. People contacted as part of the local health department's perinatal hepatitis B prevention program were offered culturally appropriate telephone patient navigation services to test if this would improve adherence with postpartum hepatitis B care. Four-hundred and nine people were enrolled in the intervention. Using laboratory-reported surveillance data as the outcome measure, those receiving the intervention were 1.66 times as likely to see a hepatitis B care provider within 6 months of childbirth compared with those who did not. Culturally appropriate patient navigation can improve adherence with recommended hepatitis B care in the postpartum period. Health departments can use similar interventions to address liver health disparities in immigrant populations.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Culturally appropriate services; Hepatitis B virus infection; Patient navigation; Public health intervention; Surveillance data

Year:  2021        PMID: 34313899     DOI: 10.1007/s10903-021-01240-5

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  2 in total

Review 1.  Health services utilization: framework and review.

Authors:  J G Anderson
Journal:  Health Serv Res       Date:  1973       Impact factor: 3.402

2.  Exacerbation of chronic hepatitis B infection after delivery.

Authors:  M J ter Borg; W F Leemans; R A de Man; H L A Janssen
Journal:  J Viral Hepat       Date:  2008-01       Impact factor: 3.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.